Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3665
Selected: 0
NCT IDTitle
NCT06277219A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
NCT01715467CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
NCT03262012Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®
NCT03265119PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations
NCT05511519Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
NCT03471767AXS-05 Phase II Trial on Smoking Behavior
NCT06263231A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
NCT04606602Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
NCT04202965PTG-300 in Subjects With Hereditary Hemochromatosis
NCT02718495Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
NCT03251092Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
NCT07682129Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
NCT01431339Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT00711477A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects
NCT02657330Study of SBP-101 in Pancreatic Cancer
NCT06343402Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
NCT03218995Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
NCT03178422Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects
NCT05611931Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT01085045Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00699712Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)
NCT07594119Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
NCT07839936A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease
NCT04385303Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)
NCT02978222Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
NCT05176639A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)
NCT05456880BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
NCT07680946Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
NCT03682770Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
NCT06087653Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
NCT02072161Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
NCT06658951Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
NCT05203237Phase 1 Study to Evaluate the Safety and Tolerability of VK2735
NCT02596477Evaluation of Vepoloxamer in Chronic Heart Failure
NCT07126873A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT05113966Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
NCT03624010Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
NCT00968942Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00765323Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
NCT02607683Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
NCT05567627Clinical Exploration of Adeno-associated Virus (AAV) Expressing Human Acid Alpha- Glucosidase (GAA) Gene Therapy for Patients With Infantile-onset Pompe Disease
NCT01516294IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD
NCT00830154A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
NCT05311215Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity
NCT05533008CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients
NCT02653625PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis
NCT02358889Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
NCT01699178Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
NCT03290378Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy
NCT05525455TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88)